Effect of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing

Journal of Orthopaedic Research

Volumn 25, Issue 9, 2007, Pages 1193-1203

  Tsiridis, Eleftherios ^a   Morgan, Elise F ^a,b   Bancroft, Jared M ^a   Song, Mike ^a   Kain, Michael ^a   Gerstenfeld, Louis ^a   Einhorn, Thomas A ^a   Bouxsein, Mary L ^c   Tornetta III, Paul ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Bone morphogenetic protein 7; Fracture healing; Metaphysis; Osteotomy; Torsion

Indexed keywords

CALCIUM PHOSPHATE; PARATHYROID HORMONE[1-34]; RECOMBINANT HUMAN OSTEOGENIC PROTEIN 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; BMP7 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; DRUG DERIVATIVE; PARATHYROID HORMONE (1 34)AMIDE; PARATHYROID HORMONE (1-34)AMIDE; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MINERAL; BONE RADIOGRAPHY; BONE STRENGTH; COMPRESSION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXTERNAL FIXATOR; FEMALE; FRACTURE HEALING; HISTOPATHOLOGY; METAPHYSIS; NONHUMAN; OSSIFICATION; OSTEOTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; RELIABILITY; REPRODUCIBILITY; TIBIA FRACTURE; TORSION; TREATMENT FAILURE; ANIMAL; BONE REGENERATION; COMPRESSIVE STRENGTH; DISEASE MODEL; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; HUMAN; INJURY; MECHANICAL STRESS; PATHOLOGY; RADIOGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIA;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; COMPRESSIVE STRENGTH; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FRACTURE HEALING; HUMANS; INJECTIONS, SUBCUTANEOUS; OSTEOTOMY; PEPTIDE FRAGMENTS; RABBITS; RECOMBINANT PROTEINS; STRESS, MECHANICAL; TERIPARATIDE; TIBIA; TORSION;

EID: 34548405276     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20420     Document Type: Article

References (33)

1. Einhorn TA. 1998. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 355 (Suppl):S7-S21.
2. Einhorn TA. 2005. The science of fracture healing. J Orthop Trauma 1934-S6.
3. Jarry L, Uhthoff HK. 1971. Differences in healing of metaphyseal and diaphyseal fractures. Can J Surg 14:127-135.
4. Uhthoff HK, Rahn BA. 1981. Healing patterns of metaphyseal fractures. Clin Orthop Relat Res 160:295-303.
5. Nunamaker DM. 1998. Experimental models of fracture repair. Clin Orthop Relat Res 355(Suppl):S56-S65.
6. Chen WJ, Jingushi S, Aoyama 1, et al. 2004. Effects of FGF-2 on metaphyseal fracture repair in rabbit tibiae. J Bone Miner Metab 22:303-309.
7. Loeys BL, Chen J, Neptune ER, et al. 2005. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275-281.
8. Cho TJ, Gerstenfeld LC, Einhorn TA. 2002. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17:513-520.
9. Reddi AH. 2001. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 83-A(Suppl 1):Sl-S6.
10. Ripamonti U, Van Den Heever B, Sampath TK, et al. 1996. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-I (hOP-1, bone morphogenetic protein-7). Growth Factors 13:273-289.
11. Cook SD, Salkeld SL, Patron LP, et al. 2002. Healing course of primate ulna segmental defects treated with osteogenic protein-1. J Invest Surg 15:69-79.
12. den Boer FC, Wippermann BW, Blokhuis TJ, et al. 2003. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow. J Orthop Res 21:521-528.
13. Salkeld SL, Patron LP, Barrack RL, Cook SD. 2001. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am 83-A:803-816.
14. Cook SD, Baffes GC, Wolfe MW, et al. 1994. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 76:827-838.
15. Makino T, Hak DJ, Hazelwood SJ, et al. 2005. Prevention of atrophic nonunion development by recombinant human bone morphogenetic protein-7. J Orthop Res 23:632-638.
16. Geesink RG, Hoefhagels NH, Bulstra SK. 1999. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81:710-718.
17. Friedlaender GE, Perry CR, Cole JD, et al. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A(Suppl 1):S151-S158.
18. Neer RM, Arnaud CD, Zanchetta JR, et al. 2001. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441.
19. Alkhiary YM, Gerstenfeld LC, Krall E, et al. 2005. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 87:731-741.
20. Andreassen TT, Ejersted C, Oxhind H. 1999. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14:960-968.
21. Holzer G, Majeska RJ, Lundy MW, et al. 1999. Parathyroid hormone enhances fracture healing. A preliminary report. Clin Orthop 366:258-263.
22. Nakajima A, Shimoji N, Shiomi K, et al. 2002. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17:2038-2047.
23. Jahng JS, Kim HW. 2000. Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Orthopedics 23:1089-1094.
24. Skripitz R, Andreassen TT, Aspenberg P. 2000. Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber. A dose-response study. J Bone Joint Surg Br 82:138-141.
25. Seebach C, Skripitz R, Andreassen TT, Aspenberg P. 2004. Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 22:472-478.
26. Tashjian AH Jr, Chabner BA. 2002. Commentary on clinical safety of recombinant human parathyroid hormone 1-34in the treatment of osteoporosis in men and post-menopausal women. J Bone Miner Res 17:1151-1161.
27. Bostrom MP, Gamradt SC, Asnis P, et al. 2000. Parathyroid hormone-related protein analog RS-66271 is an effective therapy for impaired bone healing in rabbits on corticosteroid therapy. Bone 26:437-442.
28. Jamsa T, Jalovaara P, Peng Z, et al. 1998. Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone 23:155-161.
29. Muller ME, Webber CE, Bouxsein ML. 2003. Predicting the failure load of the distal radius. Osteoporos Int 14:345-352.
30. Siu WS, Qin L, Leung KS. 2003. pQCT bone strength index may serve as a better predictor than bone mineral density for long bone breaking strength. J Bone Miner Metab 21:316-322.
31. Urist MR. 1965. Bone: formation by autoinduction. Science 150:893-899.
32. Wozney JM, Rosen V, Celeste AJ, et al. 1988. Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534.
33. Hirano, T, Burr, DB, Turner XX, et al. 1999. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodelling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 14:536-545.